nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Carboplatin—ocular cancer	0.895	1	CbGbCtD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—HRAS—ocular cancer	0.000287	0.00272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—HRAS—ocular cancer	0.000287	0.00272	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	0.000281	0.00267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—MDM2—ocular cancer	0.000276	0.00262	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.000273	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000273	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—MYC—ocular cancer	0.000271	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—MDM2—ocular cancer	0.000271	0.00258	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	0.000265	0.00252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.000263	0.0025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—HRAS—ocular cancer	0.000262	0.00249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—MDM2—ocular cancer	0.000259	0.00246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—MDM2—ocular cancer	0.000258	0.00245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—MDM2—ocular cancer	0.000256	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—AKT1—ocular cancer	0.000256	0.00243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—ocular cancer	0.000256	0.00243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—MDM2—ocular cancer	0.000255	0.00243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SAG—ocular cancer	0.000253	0.00241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—ocular cancer	0.000253	0.00241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—AKT1—ocular cancer	0.000253	0.00241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—CDKN1B—ocular cancer	0.000252	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MDM2—ocular cancer	0.000252	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—ocular cancer	0.00025	0.00238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CDKN1B—ocular cancer	0.000248	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—AKT1—ocular cancer	0.000247	0.00235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.000243	0.00231	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000241	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—MDM2—ocular cancer	0.00024	0.00228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.00024	0.00228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—MDM2—ocular cancer	0.00024	0.00228	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PSPH—ocular cancer	0.000239	0.00227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—MDM2—ocular cancer	0.000238	0.00226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000237	0.00226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—CDKN1B—ocular cancer	0.000237	0.00225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.000236	0.00224	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	0.000236	0.00224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—CDKN1B—ocular cancer	0.000235	0.00224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—MDM2—ocular cancer	0.000235	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—CDKN1B—ocular cancer	0.000234	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CDKN1B—ocular cancer	0.000233	0.00221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—CDKN1A—ocular cancer	0.000232	0.00221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—AKT1—ocular cancer	0.000231	0.0022	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—RB1—ocular cancer	0.000231	0.00219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—ocular cancer	0.00023	0.00218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000229	0.00218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CDKN1A—ocular cancer	0.000229	0.00217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—HRAS—ocular cancer	0.000226	0.00215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000226	0.00215	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	0.000225	0.00214	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—E2F5—ocular cancer	0.000224	0.00213	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.000222	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—MDM2—ocular cancer	0.000222	0.00211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000221	0.0021	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—E2F4—ocular cancer	0.00022	0.00209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CDKN1B—ocular cancer	0.000219	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.000219	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CDKN1B—ocular cancer	0.000219	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000219	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—CDKN1A—ocular cancer	0.000218	0.00207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	0.000218	0.00207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CDKN1B—ocular cancer	0.000217	0.00206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—CDKN1A—ocular cancer	0.000217	0.00206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—CDKN1A—ocular cancer	0.000216	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RBL1—ocular cancer	0.000215	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL39—ocular cancer	0.000215	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.000215	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CDKN1A—ocular cancer	0.000215	0.00204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1B—ocular cancer	0.000214	0.00204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.000213	0.00203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000213	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.000212	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—AKT1—ocular cancer	0.000211	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000211	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—ocular cancer	0.000207	0.00197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	0.000207	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000206	0.00196	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1B—ocular cancer	0.000203	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.000202	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CDKN1A—ocular cancer	0.000202	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.000202	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CDKN1A—ocular cancer	0.000201	0.00191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—AKT1—ocular cancer	0.0002	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000199	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1A—ocular cancer	0.000198	0.00188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000197	0.00187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000196	0.00187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—HRAS—ocular cancer	0.000196	0.00186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000194	0.00185	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000191	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00019	0.00181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00019	0.00181	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PSPH—ocular cancer	0.00019	0.0018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.000188	0.00179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1A—ocular cancer	0.000187	0.00178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—AKT1—ocular cancer	0.000187	0.00177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—AKT1—ocular cancer	0.000182	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000181	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000181	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—AKT1—ocular cancer	0.000181	0.00172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000181	0.00172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	0.00018	0.00171	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.00018	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000179	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SAG—ocular cancer	0.000177	0.00169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000177	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TFDP1—ocular cancer	0.000174	0.00165	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GNA11—ocular cancer	0.000174	0.00165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.000171	0.00163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MDM2—ocular cancer	0.000164	0.00155	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GNAQ—ocular cancer	0.000161	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—ocular cancer	0.000158	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000158	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000157	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F5—ocular cancer	0.000157	0.00149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000156	0.00149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—ocular cancer	0.000155	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F4—ocular cancer	0.000154	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000151	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RBL1—ocular cancer	0.000151	0.00143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SAG—ocular cancer	0.00015	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1B—ocular cancer	0.000149	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—ocular cancer	0.000149	0.00141	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—EP300—ocular cancer	0.000148	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—ocular cancer	0.000142	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.000142	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—ocular cancer	0.000141	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000141	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—ocular cancer	0.000141	0.00134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—ocular cancer	0.00014	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—ocular cancer	0.00014	0.00133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000138	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAML2—ocular cancer	0.000138	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1A—ocular cancer	0.000138	0.00131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.000137	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—ocular cancer	0.000137	0.0013	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000137	0.0013	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000134	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000134	0.00127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—E2F5—ocular cancer	0.000133	0.00126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000132	0.00126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—ocular cancer	0.000132	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—ocular cancer	0.000132	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000132	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—ocular cancer	0.000131	0.00125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F3—ocular cancer	0.000131	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—ocular cancer	0.000131	0.00124	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00013	0.00124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—E2F4—ocular cancer	0.00013	0.00124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00013	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000129	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—ocular cancer	0.000129	0.00122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL39—ocular cancer	0.000128	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RBL1—ocular cancer	0.000128	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—ocular cancer	0.000125	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—ocular cancer	0.000125	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—ocular cancer	0.000124	0.00118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—ocular cancer	0.000124	0.00118	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000122	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—ocular cancer	0.000122	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000122	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TFDP1—ocular cancer	0.000122	0.00116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000117	0.00111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000117	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—ocular cancer	0.000116	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—ocular cancer	0.000116	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000116	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—ocular cancer	0.000115	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000114	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—ocular cancer	0.000114	0.00108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000113	0.00107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000113	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000109	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—ocular cancer	0.000108	0.00102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000107	0.00102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000103	0.000979	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TFDP1—ocular cancer	0.000103	0.000978	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HDAC1—ocular cancer	0.000101	0.000959	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAML2—ocular cancer	9.66e-05	0.000918	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	9.35e-05	0.000889	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MDM2—ocular cancer	9.33e-05	0.000887	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	9.33e-05	0.000886	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—ocular cancer	9.13e-05	0.000868	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN2B—ocular cancer	9.04e-05	0.00086	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—ocular cancer	8.98e-05	0.000853	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MDM2—ocular cancer	8.96e-05	0.000851	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—ocular cancer	8.94e-05	0.000849	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1B—ocular cancer	8.52e-05	0.00081	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNA11—ocular cancer	8.43e-05	0.000801	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1B—ocular cancer	8.18e-05	0.000777	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAML2—ocular cancer	8.17e-05	0.000777	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—ocular cancer	7.93e-05	0.000753	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1A—ocular cancer	7.86e-05	0.000747	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNAQ—ocular cancer	7.84e-05	0.000745	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	7.68e-05	0.00073	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1A—ocular cancer	7.55e-05	0.000717	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNA11—ocular cancer	7.52e-05	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EP300—ocular cancer	7.48e-05	0.000711	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HDAC1—ocular cancer	7.07e-05	0.000671	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNAQ—ocular cancer	6.99e-05	0.000665	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	6.48e-05	0.000616	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—ocular cancer	6.33e-05	0.000602	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HDAC1—ocular cancer	5.98e-05	0.000568	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNA11—ocular cancer	5.97e-05	0.000568	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—E2F1—ocular cancer	5.81e-05	0.000552	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—EP300—ocular cancer	5.8e-05	0.000551	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.64e-05	0.000536	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNAQ—ocular cancer	5.55e-05	0.000528	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—ocular cancer	5.43e-05	0.000516	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—ocular cancer	5.36e-05	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—ocular cancer	5.12e-05	0.000487	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—ocular cancer	5.02e-05	0.000477	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—ocular cancer	4.96e-05	0.000471	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—ocular cancer	4.92e-05	0.000467	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—ocular cancer	4.58e-05	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—ocular cancer	4.58e-05	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—ocular cancer	4.52e-05	0.00043	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.48e-05	0.000426	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EP300—ocular cancer	4.36e-05	0.000414	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—ocular cancer	4.34e-05	0.000413	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—ocular cancer	4.23e-05	0.000402	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EP300—ocular cancer	4.02e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—ocular cancer	3.51e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—ocular cancer	3.51e-05	0.000333	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—ocular cancer	3.5e-05	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—ocular cancer	3.5e-05	0.000332	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—ocular cancer	3.21e-05	0.000305	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—ocular cancer	3.06e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—ocular cancer	2.98e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—ocular cancer	2.97e-05	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—ocular cancer	2.96e-05	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EP300—ocular cancer	2.82e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—ocular cancer	2.75e-05	0.000262	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—ocular cancer	2.71e-05	0.000258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—ocular cancer	2.63e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—EP300—ocular cancer	2.51e-05	0.000239	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—ocular cancer	2.5e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—ocular cancer	2.45e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—ocular cancer	2.45e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—ocular cancer	2.43e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EP300—ocular cancer	2.38e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—ocular cancer	2.08e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—ocular cancer	2.07e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—ocular cancer	2.02e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EP300—ocular cancer	2e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—ocular cancer	1.93e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—ocular cancer	1.7e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—ocular cancer	1.63e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—ocular cancer	1.52e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—ocular cancer	1.44e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—ocular cancer	1.21e-05	0.000115	CbGpPWpGaD
